Eli Lilly and Co是一家制药公司。该公司在全球从事医药产品的发现、开发、制造、营销和销售。该公司的糖尿病产品包括Baqsimi、Basaglar、Humalog、Humulin、Jardiance、Lyumjev、Trajenta和Trulicity。其肿瘤产品包括Alimta、Cyramza、Erbitux、Retevmo、Tyvyt和Verzenio。该公司的免疫学产品包括Olumiant和Taltz。其神经科学产品包括Cymbalta、Emgality、Reyvow和Zyprexa。其其他疗法包括Bamlanivimab、etesevimab、Cialis和Forteo。该公司通过位于美国(包括波多黎各)和其他大约八个国家的工厂生产和分销其产品。其产品销往约120个国家。其子公司包括Acanthas Pharma, Inc.、Alnara Pharmaceuticals, Inc.、ARMO Biosciences, Inc.和Avid Radiopharmaceuticals, Inc.等。
名称 | 标题 | 任期 | 年龄 |
|---|---|---|---|
| David A. Ricks | Chairman & CEO | 2017 | 58 |
| Sidney Taurel | Chairman Emeritus | 2009 | 77 |
| Ralph Alvarez | Independent Director | 2009 | 71 |
| Katherine Baicker | Independent Director | 2011 | 54 |
| Juan Ricardo Luciano | Lead Independent Director | 2019 | 65 |
| Jamere Jackson | Independent Director | 2016 | 57 |
| Jon Erik Fyrwald | Independent Director | 2005 | 67 |
| William G. Kaelin | Independent Director | 2012 | 68 |
| Carolyn R. Bertozzi | Independent Director | 2025 | 59 |
| Gabrielle Sulzberger | Independent Director | 2021 | 65 |
| Kimberly H. Johnson | Independent Director | 2021 | 53 |
| Mary Lynne Hedley | Independent Director | 2022 | 64 |
| Jon R. Moeller | Independent Director | 2024 | 62 |